BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 34660174)

  • 1. Injectable biomaterials for treatment of glioblastoma.
    Anderson AR; Segura T
    Adv Mater Interfaces; 2020 Oct; 7(20):. PubMed ID: 34660174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced biomaterials for human glioblastoma multiforme (GBM) drug delivery.
    Nozhat Z; Heydarzadeh S; Shahriari-Khalaji M; Wang S; Iqbal MZ; Kong X
    Biomater Sci; 2023 Jun; 11(12):4094-4131. PubMed ID: 37073998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer drug-loaded hydrogels as drug delivery systems for the local treatment of glioblastoma.
    Bastiancich C; Danhier P; Préat V; Danhier F
    J Control Release; 2016 Dec; 243():29-42. PubMed ID: 27693428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local delivery to malignant brain tumors: potential biomaterial-based therapeutic/adjuvant strategies.
    Alghamdi M; Gumbleton M; Newland B
    Biomater Sci; 2021 Sep; 9(18):6037-6051. PubMed ID: 34357362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM).
    Yalamarty SSK; Filipczak N; Li X; Subhan MA; Parveen F; Ataide JA; Rajmalani BA; Torchilin VP
    Cancers (Basel); 2023 Apr; 15(7):. PubMed ID: 37046777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Perspectives on Therapies, Including Drug Delivery Systems, for Managing Glioblastoma Multiforme.
    Bhaskaran M; Devegowda VG; Gupta VK; Shivachar A; Bhosale RR; Arunachalam M; Vaishnavi T
    ACS Chem Neurosci; 2020 Oct; 11(19):2962-2977. PubMed ID: 32945654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glioblastoma multiforme: Diagnosis, treatment, and invasion.
    Li J; Feng L; Lu Y
    J Biomed Res; 2022 Oct; 37(1):47-58. PubMed ID: 36403983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and structure-property relationships of an injectable thiol-Michael addition hydrogel toward compatibility with glioblastoma therapy.
    Khan ZM; Wilts E; Vlaisavljevich E; Long TE; Verbridge SS
    Acta Biomater; 2022 May; 144():266-278. PubMed ID: 35296443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Advances in the Therapeutic Strategies of Glioblastoma Multiforme.
    Aldoghachi AF; Aldoghachi AF; Breyne K; Ling KH; Cheah PS
    Neuroscience; 2022 May; 491():240-270. PubMed ID: 35395355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosine Kinase Inhibitors for Glioblastoma Multiforme: Challenges and Opportunities for Drug Delivery.
    Brar HK; Jose J; Wu Z; Sharma M
    Pharmaceutics; 2022 Dec; 15(1):. PubMed ID: 36678688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of Therapies for Glioblastoma (GBM) Using Nanoparticle-based Delivery Systems.
    Wiwatchaitawee K; Quarterman JC; Geary SM; Salem AK
    AAPS PharmSciTech; 2021 Feb; 22(2):71. PubMed ID: 33575970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A narrative review of research progress on drug therapies for glioblastoma multiforme.
    Zheng X; Tang Q; Ren L; Liu J; Li W; Fu W; Wang J; Du G
    Ann Transl Med; 2021 Jun; 9(11):943. PubMed ID: 34350258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current progress in chimeric antigen receptor T cell therapy for glioblastoma multiforme.
    Marei HE; Althani A; Afifi N; Hasan A; Caceci T; Pozzoli G; Cenciarelli C
    Cancer Med; 2021 Aug; 10(15):5019-5030. PubMed ID: 34145792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic advances in the treatment of glioblastoma: rationale and potential role of targeted agents.
    Reardon DA; Wen PY
    Oncologist; 2006 Feb; 11(2):152-64. PubMed ID: 16476836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomaterial-based
    Ahmed T
    Cancer Pathog Ther; 2023 Jul; 1(3):177-194. PubMed ID: 38327839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biocompatible copolymer formulations to treat glioblastoma multiforme.
    Erthal LCS; Gobbo OL; Ruiz-Hernandez E
    Acta Biomater; 2021 Feb; 121():89-102. PubMed ID: 33227487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanotechnology for Treatment of Glioblastoma Multiforme.
    Michael JS; Lee BS; Zhang M; Yu JS
    J Transl Int Med; 2018 Sep; 6(3):128-133. PubMed ID: 30425948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Monoclonal Antibodies Delivery for the Glioblastoma Treatment.
    Sousa F; Moura RP; Moreira E; Martins C; Sarmento B
    Adv Protein Chem Struct Biol; 2018; 112():61-80. PubMed ID: 29680243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging treatment strategies for glioblastoma multiforme.
    Carlsson SK; Brothers SP; Wahlestedt C
    EMBO Mol Med; 2014 Nov; 6(11):1359-70. PubMed ID: 25312641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Advancements and Strategies for Overcoming the Blood-Brain Barrier Using Albumin-Based Drug Delivery Systems to Treat Brain Cancer, with a Focus on Glioblastoma.
    Tincu Iurciuc CE; Andrițoiu CV; Popa M; Ochiuz L
    Polymers (Basel); 2023 Oct; 15(19):. PubMed ID: 37836018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.